Latest News

  • INSIGHTS

    24 Nov 2025

    U.S. Peptide Push Signals a New Drug Age
  • INNOVATION

    19 Nov 2025

    Peptide Producers Bet Big on Therapeutic Growth
  • INVESTMENT

    17 Nov 2025

    U.S. Labs Gear Up as Peptide Demand Surges
  • MARKET TRENDS

    13 Nov 2025

    How Far Can the GLP-1 Wave Go?

AI Duo Fast-Tracks the Peptide Revolution

AI Duo Fast-Tracks the Peptide Revolution

PARTNERSHIPS

11 Nov 2025

BioDuro and Atombeat unite AI and lab science to reinvent peptide drug discovery at record speed

Bioprocessing Applications Lab sign on a modern facility wall viewed through adjacent glass window.

INSIGHTS

24 Nov 2025

U.S. Peptide Push Signals a New Drug Age

SK pharmteco’s $6.1 million expansion boosts U.S. peptide production and future drug innovation

CPC Scientific booth showcasing peptide and oligo CDMO services at an industry event.

INNOVATION

19 Nov 2025

Peptide Producers Bet Big on Therapeutic Growth

CPC Scientific and AmbioPharm advance 2022 to 2023 expansions as CPCs Rocklin site targets 2026 operations

SK pharmteco exhibition booth with staff meeting attendees at industry event

INVESTMENT

17 Nov 2025

U.S. Labs Gear Up as Peptide Demand Surges

SK pharmteco’s $6.1 million U.S. expansion speeds peptide drug development and stabilizes supply chains

Medical syringe resting beside large blue GLP-1 text on a white background

MARKET TRENDS

13 Nov 2025

How Far Can the GLP-1 Wave Go?

Surging GLP-1 demand accelerates moves toward easier delivery, expanded capacity and faster innovation

AI Duo Fast-Tracks the Peptide Revolution

PARTNERSHIPS

11 Nov 2025

AI Duo Fast-Tracks the Peptide Revolution

BioDuro and Atombeat unite AI and lab science to reinvent peptide drug discovery at record speed

Peptides on the Rise: Amphastar’s $453M Leap Into Next-Gen Drugs

RESEARCH

7 Nov 2025

Peptides on the Rise: Amphastar’s $453M Leap Into Next-Gen Drugs

Amphastar’s $453M deal with Anji advances peptide drugs for cancer and eye disease

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.